+

WO2005112979A3 - Procédés de prévention et de traitement de la mucosite alimentaire - Google Patents

Procédés de prévention et de traitement de la mucosite alimentaire Download PDF

Info

Publication number
WO2005112979A3
WO2005112979A3 PCT/US2005/010545 US2005010545W WO2005112979A3 WO 2005112979 A3 WO2005112979 A3 WO 2005112979A3 US 2005010545 W US2005010545 W US 2005010545W WO 2005112979 A3 WO2005112979 A3 WO 2005112979A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
preventing
alimentary mucositis
treating alimentary
treating
Prior art date
Application number
PCT/US2005/010545
Other languages
English (en)
Other versions
WO2005112979A2 (fr
Inventor
Enrique Alvarez
Henri Lichenstein
Namdev K Pradyumna
Pascal Valax
Zachary Yim
Rajeev A Chillakuru
William Hahne
Michael E Jeffers
William J Larochelle
Original Assignee
Curagen Corp
Enrique Alvarez
Henri Lichenstein
Namdev K Pradyumna
Pascal Valax
Zachary Yim
Rajeev A Chillakuru
William Hahne
Michael E Jeffers
William J Larochelle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/842,206 external-priority patent/US20050256039A1/en
Priority claimed from US10/980,459 external-priority patent/US20050256042A1/en
Priority to JP2007513139A priority Critical patent/JP2007536381A/ja
Priority to AU2005244737A priority patent/AU2005244737A1/en
Priority to CA002566439A priority patent/CA2566439A1/fr
Priority to EP05765938A priority patent/EP1773372A2/fr
Application filed by Curagen Corp, Enrique Alvarez, Henri Lichenstein, Namdev K Pradyumna, Pascal Valax, Zachary Yim, Rajeev A Chillakuru, William Hahne, Michael E Jeffers, William J Larochelle filed Critical Curagen Corp
Priority to PCT/US2005/039833 priority patent/WO2006055264A1/fr
Priority to CA002586213A priority patent/CA2586213A1/fr
Priority to JP2007540036A priority patent/JP2008519032A/ja
Priority to AU2005306898A priority patent/AU2005306898A1/en
Priority to EP05851340A priority patent/EP1812460A1/fr
Publication of WO2005112979A2 publication Critical patent/WO2005112979A2/fr
Publication of WO2005112979A3 publication Critical patent/WO2005112979A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des compositions et des procédés servant à prévenir et à traiter la mucosite alimentaire. Plus particulièrement, la présente invention fournit des procédés servant à prévenir et/ou à traiter la mucosite alimentaire en utilisant des compositions comprenant du FGF-20, un fragment, un dérivé, une variante, un homologue ou un analogue de celui-ci.
PCT/US2005/010545 2004-05-10 2005-03-29 Procédés de prévention et de traitement de la mucosite alimentaire WO2005112979A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2007513139A JP2007536381A (ja) 2004-05-10 2005-03-29 消化管粘膜炎を予防または処置する方法
AU2005244737A AU2005244737A1 (en) 2004-05-10 2005-03-29 Methods of preventing and treating alimentary mucositis
CA002566439A CA2566439A1 (fr) 2004-05-10 2005-03-29 Procedes de prevention et de traitement de la mucosite alimentaire
EP05765938A EP1773372A2 (fr) 2004-05-10 2005-03-29 Procédés de prévention et de traitement de la mucosite alimentaire
EP05851340A EP1812460A1 (fr) 2004-11-03 2005-11-03 Formulations, procedes de production et utilisations du fgf-20
PCT/US2005/039833 WO2006055264A1 (fr) 2004-11-03 2005-11-03 Formulations, procedes de production et utilisations du fgf-20
AU2005306898A AU2005306898A1 (en) 2004-11-03 2005-11-03 Formulations, methods of production and uses of FGF-20
CA002586213A CA2586213A1 (fr) 2004-11-03 2005-11-03 Formulations, procedes de production et utilisations du fgf-20
JP2007540036A JP2008519032A (ja) 2004-11-03 2005-11-03 Ｆｇｆ−２０の調合物、生成方法および使用

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US84217904A 2004-05-10 2004-05-10
US10/842,206 2004-05-10
US10/842,179 2004-05-10
US10/842,206 US20050256039A1 (en) 2003-05-09 2004-05-10 Novel fibroblast growth factors and methods of use thereof
US61301304P 2004-09-22 2004-09-22
US60/613,013 2004-09-22
US62355104P 2004-10-28 2004-10-28
US60/623,551 2004-10-28
US10/980,459 2004-11-03
US10/980,459 US20050256042A1 (en) 2003-05-09 2004-11-03 Methods of preventing and treating alimentary mucositis

Publications (2)

Publication Number Publication Date
WO2005112979A2 WO2005112979A2 (fr) 2005-12-01
WO2005112979A3 true WO2005112979A3 (fr) 2009-04-09

Family

ID=35428850

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/010545 WO2005112979A2 (fr) 2004-05-10 2005-03-29 Procédés de prévention et de traitement de la mucosite alimentaire

Country Status (5)

Country Link
EP (1) EP1773372A2 (fr)
JP (1) JP2007536381A (fr)
AU (1) AU2005244737A1 (fr)
CA (1) CA2566439A1 (fr)
WO (1) WO2005112979A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055264A1 (fr) * 2004-11-03 2006-05-26 Curagen Corporation Formulations, procedes de production et utilisations du fgf-20

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007595A2 (fr) * 1999-07-27 2001-02-01 Curagen Corporation Nouveau facteur de croissance des fibroblastes et acides nucleiques codant ce dernier

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007595A2 (fr) * 1999-07-27 2001-02-01 Curagen Corporation Nouveau facteur de croissance des fibroblastes et acides nucleiques codant ce dernier

Also Published As

Publication number Publication date
CA2566439A1 (fr) 2005-12-01
AU2005244737A1 (en) 2005-12-01
JP2007536381A (ja) 2007-12-13
WO2005112979A2 (fr) 2005-12-01
EP1773372A2 (fr) 2007-04-18

Similar Documents

Publication Publication Date Title
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2008115469A3 (fr) Rôle de la signalisation par hérisson dans l'athérosclérose et les maladies cardiovasculaires
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
WO2005079756A3 (fr) Methodes et compositions de traitement de troubles psychiatriques
WO2007075525A3 (fr) Combinaison de composes organiques
WO2008011363A3 (fr) Compositions contenant de la quercétine
WO2006017295A3 (fr) Analogues de tetrapeptide
WO2007008529A3 (fr) Agents modificateurs de l'absorption du cholesterol cellulaire
WO2007112052A3 (fr) Formulations et méthodes destinées aux maladies ou aux pathologies liées à la perméabilité vasculaire
WO2007068894A3 (fr) Nouveaux composes
WO2006015159A3 (fr) Inhibiteurs de canal a potassium
WO2007052023A3 (fr) Composes
WO2007044950A3 (fr) Formes cristallines de docetaxel et leurs processus de preparation
WO2007050793A3 (fr) Methodes et compositions de traitement du syndrome de marfan et de troubles associes
WO2007121124A3 (fr) Composés organiques et leurs utilisations
WO2007121125A3 (fr) Composés organiques et leurs utilisations
WO2007050348A3 (fr) Inhibiteurs du canal potassique
WO2007036802A3 (fr) Forme dosifiee
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2006076370A3 (fr) Cyclopentanes ou cyclopentanones substitues utilises en tant qu'agents therapeutiques
WO2011017132A3 (fr) Compositions d'inhibiteurs de mk2 et procédés d'amélioration de l'excroissance des neurites, de la neuroprotection et de la régénération des nerfs
WO2008048121A3 (fr) Composés et compositions
WO2006132739A3 (fr) Nouveaux composes chimiques
WO2007109799A3 (fr) Polymorphes de malate d'eszopiclone
WO2007112121A3 (fr) Composés à base de tétracyline et procédés de traitement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007513139

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2566439

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005244737

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005765938

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005244737

Country of ref document: AU

Date of ref document: 20050329

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005244737

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005765938

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载